Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study, Journal of Cystic Fibrosis, vol.3, issue.1, pp.23-28, 2004. ,
DOI : 10.1016/j.jcf.2003.12.005
Aerosol drug delivery: developments in device design and clinical use, The Lancet, vol.377, issue.9770, pp.1032-1045, 2011. ,
DOI : 10.1016/S0140-6736(10)60926-9
Combination Therapy in Treatment of Experimental Pulmonary Aspergillosis: In Vitro and In Vivo Correlations of the Concentration-and Dose-Dependent Interactions between Anidulafungin and Voriconazole by Bliss Independence Drug Interaction Analysis, Antimicrob. Agents Chemother, pp.53-2382, 2009. ,
Inhalable Antibiotic Delivery Using a Dry Powder Co-delivering Recombinant Deoxyribonuclease and Ciprofloxacin for Treatment of Cystic Fibrosis, Pharmaceutical Research, vol.33, issue.1, pp.27-151, 2010. ,
DOI : 10.1007/s11095-009-9991-2
Can low-dose combination products for inhalation be formulated in single crystalline particles?, European Journal of Pharmaceutical Sciences, vol.40, issue.1, pp.40-56, 2010. ,
DOI : 10.1016/j.ejps.2010.02.004
In Vitro Investigation of Drug Particulates Interactions and Aerosol Performance of Pressurised Metered Dose Inhalers, Pharmaceutical Research, vol.14, issue.1, pp.125-135, 2007. ,
DOI : 10.1007/s11095-006-9130-2
Inhalation solutions ??? which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers, Journal of Cystic Fibrosis, vol.5, issue.4, pp.205-213, 2006. ,
DOI : 10.1016/j.jcf.2006.03.007
Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers, Chest, pp.124-360, 2003. ,
Characterisation of excipient-free nanoporous microparticles (NPMPs) of bendroflumethiazide, European Journal of Pharmaceutics and Biopharmaceutics, vol.69, issue.3, pp.69-1182, 2008. ,
DOI : 10.1016/j.ejpb.2008.04.020
Excipient-free nanoporous microparticles of budesonide for pulmonary delivery, European Journal of Pharmaceutical Sciences, vol.37, issue.5, pp.37-593, 2009. ,
DOI : 10.1016/j.ejps.2009.05.007
Particle engineering of materials for oral inhalation by dry powder inhalers. II???Sodium cromoglicate, International Journal of Pharmaceutics, vol.405, issue.1-2, pp.405-441, 2011. ,
DOI : 10.1016/j.ijpharm.2010.11.040
Clinical Pharmacokinetics of Inhaled Budesonide, Clinical Pharmacokinetics, vol.320, issue.6, pp.427-440, 2001. ,
DOI : 10.2165/00003088-200140060-00004
Glucocorticoid Receptor Nuclear Translocation in Airway Cells after Inhaled Combination Therapy, American Journal of Respiratory and Critical Care Medicine, vol.172, issue.6, pp.172-704, 2005. ,
DOI : 10.1164/rccm.200408-1041OC
Inhaled corticosteroids should be the first line of treatment for children with asthma, Paediatric Respiratory Reviews, vol.12, issue.4, pp.245-249, 2011. ,
DOI : 10.1016/j.prrv.2011.05.009
The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials, The American Journal of Medicine, vol.113, issue.1, pp.113-59, 2002. ,
DOI : 10.1016/S0002-9343(02)01143-9
The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis, Respiratory Medicine, vol.89, issue.3, pp.89-209, 1995. ,
DOI : 10.1016/0954-6111(95)90249-X
Anti-inflammatory therapy in cystic fibrosis, Journal of Cystic Fibrosis, vol.4, pp.45-48, 2005. ,
DOI : 10.1016/j.jcf.2005.05.010
Drug transfer through mucus, Advanced Drug Delivery Reviews, vol.48, issue.2-3, pp.48-173, 2001. ,
DOI : 10.1016/S0169-409X(01)00115-6
Disruption of the Mucus Barrier by Topically Applied Exogenous Particles, Molecular Pharmaceutics, vol.7, issue.6, pp.2280-2288, 2010. ,
DOI : 10.1021/mp100242r
Ambroxol: a multifaceted molecule with additional therapeutic potentials in respiratory disorders of childhood, Expert Opinion on Drug Discovery, vol.12, issue.2, pp.1203-1214, 2011. ,
DOI : 10.1111/j.1399-3038.2007.00630.x
Ambroxol-induced modification of ion transport in human airway Calu-3 epithelia, Biochemical and Biophysical Research Communications, vol.343, issue.2, pp.343-475, 2006. ,
DOI : 10.1016/j.bbrc.2006.03.009
Pulmonary Selectivity and Local Pharmacokinetics of Ambroxol Hydrochloride Dry Powder Inhalation in Rat, Journal of Pharmaceutical Sciences, vol.98, issue.5, pp.98-1797, 2009. ,
DOI : 10.1002/jps.21529
Development and characterisation of soluble polymeric particles for pulmonary peptide delivery, Eur, J. Pharm. Sci, pp.41-337, 2010. ,
Evaluation of HP??CD???PEG Microparticles for Salmon Calcitonin Administration via Pulmonary Delivery, Molecular Pharmaceutics, vol.8, issue.5, pp.1887-1898, 2011. ,
DOI : 10.1021/mp200231c
Transport and local metabolism of budesonide and fluticasone propionate in a human bronchial epithelial cell line (Calu???3), Journal of Pharmaceutical Sciences, vol.91, issue.6, pp.91-1561, 2002. ,
DOI : 10.1002/jps.10151
Human respiratory epithelial cell culture for drug delivery applications, European Journal of Pharmaceutics and Biopharmaceutics, vol.60, issue.2, pp.193-205, 2005. ,
DOI : 10.1016/j.ejpb.2005.02.010
A Comparison of Spray Drying and Milling in the Production of Amorphous Dispersions of Sulfathiazole/Polyvinylpyrrolidone and Sulfadimidine/Polyvinylpyrrolidone, Molecular Pharmaceutics, vol.8, issue.2, pp.532-542, 2011. ,
DOI : 10.1021/mp1003674
Influence of Formulation and Preparation Process on Ambroxol Hydrochloride Dry Powder Inhalation Characteristics and Aerosolization Properties, Drug Development and Industrial Pharmacy, vol.28, issue.9, pp.34-984, 2008. ,
DOI : 10.1016/S0378-5173(00)00347-1
Particle Engineering for Pulmonary Drug Delivery, Pharmaceutical Research, vol.5, issue.2, pp.411-437, 2007. ,
DOI : 10.1007/s11095-006-9174-3
Fundamental effects of particle morphology on lung delivery: Predictions of Stokes' law and the particular relevance to dry powder inhaler formulation and development, Pharmaceutical Research, vol.19, issue.3, pp.239-245, 2002. ,
DOI : 10.1023/A:1014426530935
Large porous particles for pulmonary drug delivery, Science, pp.276-1868, 1997. ,
The thermodynamic dissociation constants of ambroxol, antazoline, naphazoline, oxymetazoline and ranitidine by the regression analysis of spectrophotometric data, Talanta, vol.62, issue.3, pp.62-511, 2004. ,
DOI : 10.1016/j.talanta.2003.08.027
DIELECTRIC CONSTANTS OF SOME ORGANIC SOLVENT-WATER MIXTURES AT VARIOUS TEMPERATURES, Journal of the American Chemical Society, vol.54, issue.11, pp.4125-4139, 1932. ,
DOI : 10.1021/ja01350a001
Potentiometric pKa determination of water-insoluble compounds: validation study in methanol/water mixtures, International Journal of Pharmaceutics, vol.151, issue.2, pp.151-235, 1997. ,
DOI : 10.1016/S0378-5173(97)04907-7
Thermal and structural properties of ambroxol polymorphs, Journal of Thermal Analysis and Calorimetry, vol.77, issue.2, pp.77-653, 2004. ,
DOI : 10.1023/B:JTAN.0000039001.05945.42
The effect of processing parameters on particle size in ammonia-induced precipitation of zirconyl chloride under industrially relevant conditions, Powder Technology, vol.191, issue.1-2, pp.191-218, 2009. ,
DOI : 10.1016/j.powtec.2008.10.021
Inhaling medicines: delivering drugs to the body through the lungs, Nature Reviews Drug Discovery, vol.9, issue.1, pp.67-74, 2007. ,
DOI : 10.1038/nrd2153
Bioengineering of Therapeutic Aerosols, Annual Review of Biomedical Engineering, vol.4, issue.1, pp.93-107, 2002. ,
DOI : 10.1146/annurev.bioeng.4.100101.132311
Action of N-acylated ambroxol derivatives on secretion of chloride ions in human airway epithelia, Biochemical and Biophysical Research Communications, vol.380, issue.3, pp.380-586, 2009. ,
DOI : 10.1016/j.bbrc.2009.01.122
Transepithelial transport of ambroxol hydrochloride across human intestinal Caco-2 cell monolayers, General Physiology and Biophysics, vol.28, issue.3, pp.28-309, 2009. ,
DOI : 10.4149/gpb_2009_03_309
Mucus as a barrier to the permeability of hydrophilic and lipophilic compounds in the absence and presence of sodium taurocholate micellar systems using cell culture models, European Journal of Pharmaceutical Sciences, vol.8, issue.3, pp.167-175, 1999. ,
DOI : 10.1016/S0928-0987(99)00007-X
Culture of Calu-3 Cells at the Air Interface Provides a Representative Model of the Airway Epithelial Barrier, Pharmaceutical Research, vol.26, issue.7, pp.23-1482, 2006. ,
DOI : 10.1007/s11095-006-0255-0